Toms River, New Jersey
Alzheimer's disease clinical trials in Toms River, NJ
9 Alzheimer's disease studies are recruiting participants at sites in Toms River as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Toms River at a glance
- 9 studies are recruiting at a site in Toms River.
- By phase: Phase 1 (1), Phase 2 (5), Phase 3 (3).
- By sponsor: industry (9).
- Most recent update to one of these records: November 3, 2026.
Studies recruiting in Toms River
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Bio Behavioral Health
- Registry record
- NCT06540833 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Bio Behavioral Health
- Registry record
- NCT06651567 · updated
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Bio Behavioral Health
- Registry record
- NCT07011745 · updated
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- Phase 1
- Ages 50 to 85
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- CenExel AMRI
- Registry record
- NCT06297590 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Advanced Memory Research Institute - CenExel - PPDS
- Registry record
- NCT06585787 · updated
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Phase 3
- Ages 60 to 85
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Advanced Memory Research Institute of New Jersey
- Registry record
- NCT06976216 · updated
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Phase 2
- Ages 55 to 80
- All sexes
- Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Study site
- CenExel Research - Toms River
- Registry record
- NCT06847321 · updated
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- Celgene
- Study site
- Ocean Medical Research
- Registry record
- NCT06808984 · updated
Open-label Extension Study in Participants With Early Alzheimer's Disease
- Phase 2
- Ages 50 to 85
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT07105709 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Toms River, NJ on ClinicalTrials.gov.
Ask about studies near Toms River
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections